Enhanced glucuronide formation in different tissues following drug administration.
D000605:Amino Alcohols; D000818:Animals; D001580:Benzopyrenes / Q000494:pharmacology*; D001711:Biotransformation; D002432:Cecum / Q000378:metabolism; D003106:Colon / Q000378:metabolism; D004064:Digestive System / Q000378:metabolism; D004386:Duodenum / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism; D005965:Glucuronates / Q000096:biosynthesis*; D007263:Infusions, Parenteral; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology*; D009928:Organ Specificity; D010634:Phenobarbital / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*; D013268:Stimulation, Chemical; D013997:Time Factors
D000605:Amino Alcohols; D001580:Benzopyrenes; D005965:Glucuronates; D011804:Quinolines; D012459:Salicylates; D008748:Methylcholanthrene; D010634:Phenobarbital